ANX-188 Thorough QT/QTc Study in Healthy Volunteers

NCT01790087 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: ANX-188 Therapeutic Dose
DRUG: ANX-188 Supratherapeutic dose
DRUG: Saline
DRUG: Moxifloxacin

Sponsor

Mast Therapeutics, Inc.